Add
TSRO to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| TSRO > SEC Filings for TSRO > Form 8-K on 14-Feb-2013 | All Recent SEC Filings |
14-Feb-2013
Results of Operations and Financial Condition, Regulation FD Disclosure, Financial S
On February 14, 2013, TESARO, Inc. issued a press release announcing its operating results for the quarter and year ending December 31, 2012. A copy of the press release is attached to this current report as Exhibit 99.1 and is incorporated herein by reference.
Attached as Exhibit 99.2 are slides being presented by TESARO, Inc. to discuss the development status of niraparib.
The information contained in this current report, including Exhibits 99.1 and 99.2, are being furnished to the Securities and Exchange Commission and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to liabilities under that section. Furthermore, such information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
(d) Exhibits.
Exhibit No. Description
99.1 TESARO, Inc. press release dated February 14, 2013 announcing
operating results for the quarter and year ending December 31, 2012
99.2 TESARO, Inc. slides on development status of niraparib, dated
February 2013
|
|
|